DaehanPharmaceutical operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DaehanPharmaceutical with three other
companies in this sector in KOREA (SOUTH) :
Kyongbo Pharmaceutical Co Ltd
sales of 191.71 billion Korean Won [US$173.69 million]
of which 37%
was General API),
CKD Bio Corp
(137.18 billion Korean Won [US$124.29 million]
of which 100%
was Pharmaceutical Manufacturing), and
Kolon Life Science Incorporation
(148.54 billion Korean Won [US$134.58 million]
of which 98%
DaehanPharmaceutical reported sales of 168.76 billion Korean Won (US$152.90 million)
December of 2019.
increase of 6.3%
versus 2018, when the company's sales were 158.72 billion Korean Won .
Sales at DaehanPharmaceutical have increased during each of the previous five years
(and since 2014, sales have increased a total of 51%).